What sounds like an unequal David - Goliath battle may be the key to a new therapeutic approach in the fight against COVID-19 disease.
2-deoxy-D-glucose is a glucose molecule in which the hydroxyl group in the 2 position has been replaced by hydrogen.
Chiral HPLC separation of budesonide
In the fight against COVID-19 pandemic, drugs already approved for treatment are also being tested for potential efficacy. In doing so, drugs from the related therapeutic application spectrum; i.e. viral infectious diseases; are not the only types being investigated.
In the search for effective therapeutics for COVID-19 patients, active ingredients that have shown treatment success against similar coronaviruses or influenza viruses are also included in studies.
Ph. Eur. HPLC identification of Ivermectin – Another potential “Anti-SARS-CoV-2 fighter?”
See how HPLC analysis time of the two epimers Dexamethasone and Betamethasone can be reduced to a fifth by using a MACHEREY-NAGEL Pentafluorophenyl core-shell silica column without loss in resolution. In comparison the same separation performed on a conventional totally porous column with the same surface chemistry.